Ulipristal acetate, a selective progesterone receptor modulator, combined with misoprostol resulted in pregnancy termination among nearly all participants in a small proof-of-concept study.

Ulipristal acetate (UPA) is a second-generation SPRM that exerts high-affinity binding to the human progesterone receptor. It is used for EC in a single dose of 30 mg, to be taken within 120 h of ...

Recently, a new formulation consisting of a new selective progesterone receptor modulator, ulipristal acetate, has been licensed in several European countries and in the USA. At the single dose of ...

In the study, 133 women who were up to nine weeks' pregnant took a 60 milligram dose of ulipristal acetate, the active ingredient in the prescription contraceptive Ella, followed by misoprostol 24 ...